Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Endocrine-Related Cancer|October 28, 2020
Limited efficacy of lenvatinib in heavily pretreated anaplastic thyroid cancer: a French overviewClotilde Sparano, Yann Godbert, Marie Attard, et al.
Frontiers in Endocrinology|June 11, 2025
Use and utility of endocrine multidisciplinary tumour board: an appraisal from a tertiary centreClotilde Sparano, Letizia Canu, Giuliano Perigli, et al.
World Journal of Surgical Oncology|June 27, 2023
Hemodynamic parameters in patients undergoing surgery for pheochromocytoma/paraganglioma: a retrospective studyGiuseppina De Filpo, Gabriele Parenti, Clotilde Sparano, et al.
Andrology|May 25, 2023
Does an increase in adipose tissue 'weight' affect male fertility? A systematic review and meta-analysis based on semen analysis performed using the WHO 2010 criteriaDaniele Santi, Francesco Lotti, Clotilde Sparano, et al.
Journal of the Endocrine Society|November 18, 2022
Classic and Follicular Variant of Papillary Thyroid Microcarcinoma: 2 Different Phenotypes Beyond Tumor SizeClotilde Sparano, Mario Rotondi, Valentina Verdiani, et al.
Frontiers in Endocrinology|January 25, 2024
Hypogonadism and sexual function in men affected by adrenocortical carcinoma under mitotane therapyLetizia Canu, Clotilde Sparano, Lara Naletto, et al.
Frontiers in Immunology|August 1, 2022
Gastric Th17 Cells Specific for H<sup>+</sup>/K<sup>+</sup>-ATPase and Serum IL-17 Signature in Gastric AutoimmunityChiara Della Bella, Antonio Antico, Maria Piera Panozzo, et al.
International Journal of Molecular Sciences|September 23, 2022
Prognostic role of hERG1 Potassium Channels in Neuroendocrine Tumours of the Ileum and PancreasJessica Iorio, Lorenzo Antonuzzo, Emanuela Scarpi, et al.
Andrology|April 6, 2026
Living Together, Loving Apart: Health, Sexuality and Relationships in Middle-Aged and Older Men in EuropeClotilde Sparano, Giammarco Alderotti, Giulia Rastrelli, et al.
The Oncologist|January 22, 2026
Everolimus as maintenance therapy in advanced neuroendocrine neoplasms: Results from the MAVERIC Phase II Trial (1499 WORDS MAIN TEXT)Lorenzo Antonuzzo, Daniele Lavacchi, Francesca Spada, et al.
Pageof 4